Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Filings indexed 1,392 across all filing types
Latest filing 2010-06-02 Director's Dealing
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2010-06-02 English
4 Filing
Director's Dealing
2010-05-27 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 25, 2010, for Ligand Pharmaceuticals Incorporated. The key content is Item 5.07, which details the submission of matters to a vote of security holders at the 2010 annual meeting. It includes voting results for the election of board members and ratification of the independent auditor. The document is relatively short (3155 characters) and focuses on reporting the official voting results from the shareholder meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an Annual Report, Audit Report, or Management Information, nor is it a proxy solicitation or presentation. Therefore, the correct classification is DVA with high confidence.
2010-05-27 English
4 Filing
Director's Dealing
2010-05-27 English
4 Filing
Director's Dealing
2010-05-27 English
4 Filing
Director's Dealing
2010-05-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.